DK0746613T3 - Rekombinante humaniserede antistoffer mod FB5 - Google Patents

Rekombinante humaniserede antistoffer mod FB5

Info

Publication number
DK0746613T3
DK0746613T3 DK95913660T DK95913660T DK0746613T3 DK 0746613 T3 DK0746613 T3 DK 0746613T3 DK 95913660 T DK95913660 T DK 95913660T DK 95913660 T DK95913660 T DK 95913660T DK 0746613 T3 DK0746613 T3 DK 0746613T3
Authority
DK
Denmark
Prior art keywords
humanized
antibodies
specific antibodies
provides
specific
Prior art date
Application number
DK95913660T
Other languages
English (en)
Inventor
Francis J Carr
Lloyd J Old
Thomas P Wallace
Wolfgang J Rettig
Pilar Garin-Chesa
William J Harris
Original Assignee
Sloan Kettering Inst Cancer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sloan Kettering Inst Cancer filed Critical Sloan Kettering Inst Cancer
Application granted granted Critical
Publication of DK0746613T3 publication Critical patent/DK0746613T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK95913660T 1994-03-08 1995-03-08 Rekombinante humaniserede antistoffer mod FB5 DK0746613T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20777894A 1994-03-08 1994-03-08

Publications (1)

Publication Number Publication Date
DK0746613T3 true DK0746613T3 (da) 2006-09-25

Family

ID=22771976

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95913660T DK0746613T3 (da) 1994-03-08 1995-03-08 Rekombinante humaniserede antistoffer mod FB5

Country Status (8)

Country Link
US (4) US5811522A (da)
EP (1) EP0746613B1 (da)
AT (1) ATE327330T1 (da)
AU (1) AU688880B2 (da)
CA (1) CA2185116A1 (da)
DE (1) DE69535002T2 (da)
DK (1) DK0746613T3 (da)
WO (1) WO1995024483A1 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342757A (en) * 1992-11-13 1994-08-30 Ludwig Institute For Cancer Research Monoclonal antibodies which specifically binds to endosialin, a 165 Kd glycoprotein found on tumor vascular endothelium, and uses thereof
WO1995024483A1 (en) * 1994-03-08 1995-09-14 Scotgen Biopharmaceuticals, Inc. Recombinant humanized anti-fb5 antibodies
HRP20010414A2 (en) * 1998-12-02 2002-06-30 Pfizer Prod Inc METHODS AND COMPOSITIONS FOR RESTORING CONFORMATIONAL STABILITY OF A PROTEIN OF THE p53 FAMILY
EP2039368A3 (en) 1999-04-30 2009-04-01 La Jolla Institute For Allergy And Immunology Methods for preventing reactivation of latent virus and controlling virus replication
EP1307557A2 (en) * 2000-08-02 2003-05-07 The Johns Hopkins University Endothelial cell expression patterns
JP4694128B2 (ja) 2002-01-30 2011-06-08 ザ ブライハム アンド ウイメンズ ホスピタル， インコーポレイテッド ＴＩＭ−３、Ｔｈ１特異的細胞表面分子に関連した組成物および方法
US7501494B2 (en) 2003-01-15 2009-03-10 United Biomedical, Inc. Designed deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection
KR20060003860A (ko) * 2003-03-04 2006-01-11 기린 비루 가부시키가이샤 내피 세포 특이적 항체 및 그의 용도
WO2005086713A2 (en) * 2004-03-04 2005-09-22 Kirin Brewery Co., Ltd. Role of human endothelial precursor cells and vascular pericytes tumor in angiogenesis
KR101076578B1 (ko) 2004-06-23 2011-10-24 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 2입자 착물을 이용한 생물학적 분자의 검출을 위한 방법 및조성물
WO2006060719A2 (en) * 2004-12-03 2006-06-08 Morphotek, Inc. Use of endosialin binding proteins to isolate endosialin positive cells
AU2006241235B2 (en) 2005-04-22 2012-04-05 Eisai, Inc. Antibodies with immune effector activity and that internalize in endosialin-positive cells
EP2620451B1 (en) 2007-04-05 2016-09-14 Morphotek, Inc. Methods for inhibiting the binding of endosialin to ligands
EA009327B1 (ru) * 2007-04-27 2007-12-28 Петр Генриевич ЛОХОВ Способ получения противоопухолевой вакцины на основе поверхностных антигенов эндотелиальных клеток
WO2009014835A2 (en) * 2007-06-21 2009-01-29 Angelica Therapeutics, Inc. Modified toxins
EP2268297A4 (en) * 2008-02-29 2011-11-16 Angelica Therapeutics Inc MODIFIED TOXINS
JP5839467B2 (ja) * 2009-03-06 2016-01-06 ユニベルシテ パリ デカルト 癌を治療するための方法
WO2010118203A2 (en) * 2009-04-09 2010-10-14 Morphotek, Inc. Endosialin binding molecules
US9556272B2 (en) 2009-11-11 2017-01-31 The Trustees Of The University Of Pennsylvania Anti-TEM1 antibodies and uses thereof
WO2013162748A1 (en) * 2012-04-27 2013-10-31 The Trustees Of The University Of Pennsylvania Anti-tumor endothelial marker-1 (tem1) antibody variants and uses thereof
HK1220376A1 (zh) 2013-03-15 2017-05-05 Angelica Therapeutics, Inc. 修饰的毒素
SG11201702056YA (en) 2014-09-16 2017-04-27 United Biomedical Inc Treatment and functional cure of hiv infection by monoclonal antibodies to cd4 mediating competitive hiv entry inhibition
CA3033728A1 (en) 2016-08-13 2018-02-22 Ubi Ip Holdings Treatment and sustained virologic remission of hiv infection by antibodies to cd4 in haart stabilized patients

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308235D0 (en) * 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5225539A (en) * 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
GB8607679D0 (en) * 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US5342757A (en) * 1992-11-13 1994-08-30 Ludwig Institute For Cancer Research Monoclonal antibodies which specifically binds to endosialin, a 165 Kd glycoprotein found on tumor vascular endothelium, and uses thereof
WO1995024483A1 (en) * 1994-03-08 1995-09-14 Scotgen Biopharmaceuticals, Inc. Recombinant humanized anti-fb5 antibodies

Also Published As

Publication number Publication date
DE69535002D1 (de) 2006-06-29
ATE327330T1 (de) 2006-06-15
CA2185116A1 (en) 1995-09-14
AU1996495A (en) 1995-09-25
WO1995024483A1 (en) 1995-09-14
EP0746613A1 (en) 1996-12-11
DE69535002T2 (de) 2006-12-07
US5811522A (en) 1998-09-22
US6391302B1 (en) 2002-05-21
US6217868B1 (en) 2001-04-17
US6090930A (en) 2000-07-18
AU688880B2 (en) 1998-03-19
EP0746613B1 (en) 2006-05-24

Similar Documents

Publication Publication Date Title
ATE327330T1 (de) Rekombinante humanisierte antikörper gegen fb5
DK0749482T3 (da) Rekombinante humaniserede anti-Lewis Y antistoffer
NO175944C (no) Monoklonale antistoffer for anvendelse til in vitro påvisning av tumorassosiert mucinantigen, og hybridomcellelinjer som produserer disse
HUT52153A (en) Process for producing chimeric antibody specific to human tumour antigene
DE69734109D1 (de) Humanisierung von anti-carcinoembryonalen Antigen anti-idiotypischen Antikörper und dessen Verwendung als Tumorvakzin und zur Markierung
NO963589D0 (no) Beskrivelse av kreftilstander ved MAGE-genuttrykking
ES8900247A1 (es) Un metodo de detecion y diagnostico de cancer empleando un nuevo antigeno asociado a un tumor.
ES8800603A1 (es) Un metodo para producir anticuerpos monoclonales
EP0495910A4 (en) Production and use of human nm23 protein and antibodies therefor
NO20004251L (no) Humaniserte anti-CEA monoklonale antistoffer med høy affinitet
ATE288960T1 (de) Humanisierte monoklonale antikörper mit hoher affinität gegen tag-72
DE3580524D1 (de) Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen.
DK329789D0 (da) Monoklonalt antistof
AU5752490A (en) A novel tumor associated antigen
AU5790390A (en) A novel tumor associated antigen
SE8401946D0 (sv) Antibody to human prostate cancer
JPS6444856A (en) Anti-cancer antigen anti-serum
FI961439L (fi) Menetelmä terapeuttisesti käyttökelpoisen vasta-aineen tai vasta-ainefragmentin valmistamiseksi